Immunogenicity and safety of an AS03A-adjuvanted H5N1 influenza vaccine in a Taiwanese population-Reference-Cited by-同舟云学术

Immunogenicity and safety of an AS03A-adjuvanted H5N1 influenza vaccine in a Taiwanese population

Published:2011-12 Issue:12 Volume:110 Page:780-786
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Hwang Shinn-Jang,Chang Shan-Chwen,Yu Chong-Jen,Chan Yu-Jiun,Chen Tzeng-Ji,Hsieh Shie-Liang,Lai Hsiu-Yun,Lin Ming-Hsien,Liu Jui-Yao,Ong Gary,Roman Francois,Dramé Mamadou,Bock Hans L.,Yang Pan-Chyr

Publisher

Elsevier BV

Subject

General Medicine

Reference14 articles.

1. Influenza A (H5N1): an overview of the current situation;Melidou;Eurosurveillance,2009

2. World Health Organization (WHO). Pandemic (H1N1) 2009 – update 101. May 21, 2010. Global alert and response (GAR). http://www.who.int/csr/don/2010_05_21/en/index.html [accessed 27.05.10].

3. Influenza A (H5N1): will it be the next pandemic influenza? Are we ready?;Bartlett;Ann Intern Med,2005

4. World Health Organization (WHO). Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO, 6 May 2010. Global alert and response (GAR). http://www.who.int/csr/disease/avian_influenza/country/en/ [accessed 27.05.10].

5. Comprehensive report of prevention strategy for influenza pandemic;Taiwan Epidemiol Bull,2008

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avian Influenza Virus A(H5Nx) and Prepandemic Candidate Vaccines: State of the Art;International Journal of Molecular Sciences;2024-08-05

2. Mind the Gap—A Perspective on Strategies for Protecting against Bacterial Infections during the Period from Infection to Eradication;Microorganisms;2023-06-29

3. Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines;Vaccine;2021-01

4. Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial;PLOS ONE;2017-01-18

5. Safety, Immunogenicity, and Antibody Persistence following an Investigational Streptococcus pneumoniae and Haemophilus influenzae Triple-Protein Vaccine in a Phase 1 Randomized Controlled Study in Healthy Adults;Clinical and Vaccine Immunology;2014-01